157 related articles for article (PubMed ID: 37137851)
1. [Meta-analysis of the clinical efficacy of live bifidobacterium bacteria preparation combined with entecavir in the treatment of hepatitis B virus-related cirrhosis].
Chen H; Yuan HX; Li XH
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):258-264. PubMed ID: 37137851
[No Abstract] [Full Text] [Related]
2. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.
Peng D; Xing HY; Li C; Wang XF; Hou M; Li B; Chen JH
BMC Gastroenterol; 2020 Oct; 20(1):348. PubMed ID: 33076834
[TBL] [Abstract][Full Text] [Related]
3. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
Ye XG; Su QM
World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
[TBL] [Abstract][Full Text] [Related]
4. Compound Biejia-Ruangan tablet as an adjunctive therapy to entecavir for chronic hepatitis B complicated with hepatic fibrosis: A systematic review and meta-analysis of randomized controlled trials.
Xu YH; Xue C
Medicine (Baltimore); 2022 Aug; 101(32):e30020. PubMed ID: 35960113
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis.
Zhang T; Yang Y; Wang B; Zheng X; Wang L; Feng X; Li G; Shi J; Cao N
Medicine (Baltimore); 2019 Dec; 98(51):e18458. PubMed ID: 31861022
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE.
Wan L; Hu C; Wang F; Xu K; Li F; He B; Wu Z; Luo L; Wen Z
Sci Rep; 2023 Nov; 13(1):19616. PubMed ID: 37949927
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of Entecavir monotherapy switched from Lamivudine combined Adefovir Dipivoxil for chronic hepatitis B virus-related compensated liver cirrhosis].
Lai XJ; Lian JS; Chen JY; Zhang YM; Jia HY; Zheng L; Yang YD
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):113-118. PubMed ID: 29804377
[No Abstract] [Full Text] [Related]
8. [Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].
Duan SH; Bao ZY; Yuan XD; Wang L; Liu MS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):535-8. PubMed ID: 27386642
[TBL] [Abstract][Full Text] [Related]
9. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis.
Cheng DY; Zhao ZM; Wan G; Zheng HW; Huang JQ; Liu CH; Xing HC
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):479-484. PubMed ID: 35346577
[TBL] [Abstract][Full Text] [Related]
10. Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.
Marengo A; Bitetto D; D'Avolio A; Ciancio A; Fabris C; Marietti M; Toniutto P; Di Perri G; Rizzetto M; Marzano A
Antivir Ther; 2013; 18(1):87-94. PubMed ID: 22872649
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of Chinese patent medicine combined with entecavir for the treatment of chronic HBV-related liver fibrosis or cirrhosis: Protocol for a systematic review and meta-analysis of randomized controlled trials or prospective cohort studies.
Song Y; Zhao J; Wang S; Huang H; Hong J; Zuo J; Huo S
Medicine (Baltimore); 2019 May; 98(22):e15732. PubMed ID: 31145288
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis.
Han Y; Zeng A; Liao H; Liu Y; Chen Y; Ding H
Int Immunopharmacol; 2017 Jan; 42():168-175. PubMed ID: 27915131
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
Wu QJ; Lv WL; Li JM; Zhang TT; Zhou WH; Zhang Q; Wang JC; Wang QN; Zhang RX; Zhao X; Chen ST; Liu S; Li GH; Cao ZM; Xu L; Chen J
Trials; 2020 Jun; 21(1):482. PubMed ID: 32503608
[TBL] [Abstract][Full Text] [Related]
14. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
15. [Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].
Miao L; Yang WN; Dong XQ; Zhang ZQ; Xie SB; Zhang DZ; Zhang XQ; Cheng J; Zhang G; Zhao WF; Xie Q; Liu YX; Ma AL; Li J; Shang J; Bai L; Cao LH; Zou ZQ; Li JB; Lyu FD; Liu H; Wang ZJ; Zhang MX; Chen LM; Liang WF; Gao H; Zhuang H; Zhao H; Wang GQ
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):521-526. PubMed ID: 31357778
[No Abstract] [Full Text] [Related]
16. Nucleoside analogs assisted with Chinese compound prescription in treating hepatic fibrosis of chronic hepatitis B patients: A protocol of systematic review and meta-analysis.
Cheng M; Feng X; Wang L; Yang Y; Ma L; Wang B
Medicine (Baltimore); 2020 Jul; 99(27):e21032. PubMed ID: 32629728
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis.
Chen MB; Wang H; Zheng QH; Zheng XW; Fan JN; Ding YL; Niu JL
PLoS One; 2019; 14(11):e0224773. PubMed ID: 31751366
[TBL] [Abstract][Full Text] [Related]
18. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
Goyal SK; Dixit VK; Shukla SK; Ghosh J; Behera M; Tripathi M; Gupta N; Ranjan A; Jain AK
Indian J Gastroenterol; 2015 Jul; 34(4):286-91. PubMed ID: 26243587
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of efficacy and safety of Liuwei Wuling Tablets combined with conventional drugs in treatment of liver fibrosis and cirrhosis in chronic hepatitis B].
Hou MT; Ding KX; He TT; Yang Y; Bai ZF; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):224-234. PubMed ID: 35178929
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
